# Nanotechnology for Detection of Multiple Sclerosis Compared to Autoimmune and Neurological Diseases by Exhaled Samples

> **NCT01465087** · NA · COMPLETED · sponsor: **Carmel Medical Center** · enrollment: 314 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **OTHER:** NA-NOSE artificial olfactory system

## Key facts

- **NCT ID:** NCT01465087
- **Lead sponsor:** Carmel Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-12
- **Primary completion:** 2014-02
- **Final completion:** 2015-01
- **Target enrollment:** 314 (ACTUAL)
- **Last updated:** 2016-06-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01465087

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01465087, "Nanotechnology for Detection of Multiple Sclerosis Compared to Autoimmune and Neurological Diseases by Exhaled Samples". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01465087. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*